ELISpot and FluoroSpot Assay Market

ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplant, Vaccines, Clinical Trials, Cancer), End User (Hospital, Labs, Research Institute) - Global Forecast to 2023

Report Code: MD 6791 Dec, 2018, by marketsandmarkets.com

[111 Pages Report] The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period. Growth in this market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers. On the other hand, the availability of alternative detection technologies is expected to limit market growth during the forecast period.

ELISpot and FluoroSpot Assay Market

“Assay Kits are expected to account for the largest share of the market in 2018”

By product type, the ELISpot and FluoroSpot market is segmented into assay kits, analyzers, and ancillary products. The assay kits segment accounted for the largest share in 2018, and this trend is expected to continue during the forecast period. The rising incidence of chronic diseases and technological advancements are driving the growth of this product segment.

“Increasing use of ELISpot kits in diagnostic applications in 2018”

Based on the applications, the ELISpot and FluoroSpot market is segmented into diagnostic and research applications. The diagnostics applications segment is further classified into infectious diseases and transplants. In 2018, the diagnostic segment is expected to account for the larger share of the market. The large share of this segment is attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.

ELISpot and FluoroSpot Assay Market

“Asia Pacific to grow at the highest rate during the forecast period (2018–2023)”

The ELISpot and FluoroSpot market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America is expected to dominate the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in APAC is largely driven by the large patient population and high prevalence of chronic diseases in this region.

Key Market Players

Some of the prominent players in the ELISpot and FluoroSpot are Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), and Abcam (UK).

Oxford Immunotec is the leading player in the ELISpot and FluoroSpot market. The company focuses on the development of diagnostic kits for the early detection of diseases such as TB and tick-borne diseases. The company has its presence across the globe and to maintain and improve its presence in the market; Oxford Immunotec adopted both organic as well as inorganic strategies. The company also invests a significant amount on research and development activities. In 2017, it spent around 16% of its revenue on R&D activities, which is higher than most of its counterparts.

Cellular Technology Limited (CTL) is among the pioneers of the ELISpot and FluoroSpot assays. The company developed the first ELISpot analyzers and has been leading the analyzers market ever since. It also offers ELISpot and FluoroSpot kits for detection of multiple analytes. The company’s assay kits are available for the detection of cytokines, antibodies as well as other analytes such as granzymes. The analyzers from CTL are able to detect up to 8 colors.

Recent developments:

  • In 2018, Mabtech launched IRIS analyzer
  • In 2018, Mabtech launched the human IL3 ELISpot kit
  • In 2017, Lophius Biosciences launched Next Gen. T Track CMV
  • In 2016, Lophius Biosciences launched ELISpot MultiTrack 12 x 8-well PVDF microtiter strip plate
  • In 2015, Lophius Biosciences launched T-Track ImmunoScan and T-activated ImmunoScan Cocktail

Key questions addressed in the report:

  • What are the growth opportunities in the ELISpot and FluoroSpot market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of ELISpot and FluoroSpot products. Will this scenario continue during the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the various ELISpot and FluoroSpot product types and their respective market shares in the overall market?
  • What are the new trends and advancements in the ELISpot and FluoroSpot market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 28)
    4.1 ELISpot and FluoroSpot: Market Overview
    4.2 North America: ELISpot and FluoroSpot Market, By Product (2018)
    4.3 Geographical Snapshot of the ELISpot and FluoroSpot Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Global Incidence of Chronic Diseases
                    5.2.1.2 Increasing Vaccine Development to Address the Challenge of Antimicrobial Resistance
                    5.2.1.3 Technological Advancements in ELISpot and FluoroSpot Assay Kits and Analyzers
           5.2.2 Opportunities
                    5.2.2.1 Use of FluoroSpot Assays for Multiple-Analyte Detection in A Single Well
           5.2.3 Challenges
                    5.2.3.1 Availability of Alternative Detection Technologies

6 ELISpot and FluoroSpot Market, By Product (Page No. - 34)
    6.1 Introduction
    6.2 Assay Kits
           6.2.1 Assay Kits Market, By Technique
                    6.2.1.1 ELISpot Assay Kits
                               6.2.1.1.1 Majority of Kits Available in the Market are ELISpot Kits
                    6.2.1.2 FluoroSpot Assay Kits
                               6.2.1.2.1 Increasing Demand for Multiple Analyte Detection and Technological Advancement are Driving Segmental Growth
           6.2.2 Assay Kits Market, By Utility
                    6.2.2.1 Diagnostic Kits
                               6.2.2.1.1 Diagnostic Kits are Six to Eight Times Costlier Than Research Kits
                    6.2.2.2 Research Kits
                               6.2.2.2.1 Market Growth Driven By Continued Investment in Vaccine Research, Clinical Trials, and Cancer Research
           6.2.3 Assay Kits Market, By Analyte
                    6.2.3.1 T-Cell-Based Kits
                               6.2.3.1.1 Low Concentrations of Infection-Released Analytes Necessitates Use of T-Cell-Based Kits
                    6.2.3.2 B-Cell-Based Kits
                               6.2.3.2.1 Detection of B-Cell-Based Antibodies is Useful to Study Cell Response Post-Infection/Vaccination
                    6.2.3.3 Other Analyte Kits
    6.3 Analyzers
           6.3.1 Adoption of Assay Kits Will Drive the Use of Analyzers
    6.4 Ancillary Products
           6.4.1 Market Players Such as Thermo Fisher Scientific Provide Ancillary Products

7 ELISpot and FluoroSpot Market, By Application (Page No. - 44)
    7.1 Introduction
    7.2 Diagnostic Applications
           7.2.1 Infectious Diseases
                    7.2.1.1 Infectious Diseases Segment to Dominate the Diagnostic Applications Market During the Forecast Period
           7.2.2 Transplants
                    7.2.2.1 Growing Incidence of Infections Caused During Transplant Procedures are Driving the Demand for ELISpot and FluoroSpot Assays
    7.3 Research Applications
           7.3.1 Vaccine Development
                    7.3.1.1 Vaccine Development Segment to Register the Highest Growth Rate in the Forecast Period
           7.3.2 Clinical Trials
                    7.3.2.1 Growing Number of Clinical Trials are Driving the Demand for ELISpot and FluoroSpot Assays
           7.3.3 Cancer Research
                    7.3.3.1 Rising Global Prevalence of Cancer is Driving the Growth of the ELISpot and FluoroSpot Market

8 ELISpot and FluoroSpot Market, By End User (Page No. - 53)
    8.1 Introduction
    8.2 Hospitals & Clinical Laboratories
           8.2.1 Hospitals & Clinical Laboratories to Account for the Largest Market Share in 2018
    8.3 Research Institutes
           8.3.1 Research Institutes are the Fastest-Growing End Users of the ELISpot and FluoroSpot Market
    8.4 Biopharmaceutical Companies
           8.4.1 Biopharmaceutical Companies Use ELISpot and FluoroSpot Assays for Vaccine Development, Clinical Trials, and Cancer Research

9 ELISpot and FluoroSpot Market, By Region (Page No. - 58)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 The US Will Continue to Dominate the North American ELISpot and FluoroSpot Market During the Forecast Period
           9.2.2 Canada
                    9.2.2.1 High Burden of Chronic Diseases in the Country to Drive the Adoption of ELISpot and FluoroSpot Assays
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Germany to Be the Fastest-Growing Country in the European ELISpot and FluoroSpot Market
           9.3.2 UK
                    9.3.2.1 Rising Prevalence of Ncds in the UK to Drive Market Growth
           9.3.3 France
                    9.3.3.1 Chronic Ncds Form A Key Cause of Death in France
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 China’s Large Vaccine Industry Provides Favorable Outlook for ELISpot and FluoroSpot Assays
           9.4.2 India
                    9.4.2.1 High Incidence of Chronic Diseases and Growing Vaccine R&D Activity Will Contribute to Market Growth
           9.4.3 Japan
                    9.4.3.1 Chronic Ncds are Responsible for A Large Chunk of Deaths in Japan
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 84)
     10.1 Overview
     10.2 Market Ranking Analysis, 2017
             10.2.1 Top Players in Research-Use Kits Market
             10.2.2 Top Players in ELISpot and FluoroSpot Analyzers Market
     10.3 Key Strategies
             10.3.1 Product Launches
             10.3.2 Expansions
             10.3.3 Agreements
             10.3.4 Acquisitions
             10.3.5 Patents
             10.3.6 Product Approval

11 Company Profiles (Page No. - 89)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Oxford Immunotec
     11.2 Cellular Technology Limited (CTL)
     11.3 Mabtech AB
     11.4 Becton, Dickinson and Company
     11.5 Abcam
     11.6 Bio-Techne
     11.7 Autoimmun Diagnostika GmbH
     11.8 Biotech Investissement Group
     11.9 Lophius Biosciences GmbH
     11.10 U-Cytech Biosciences

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 105)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (74 Tables)

Table 1 ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 2 ELISpot and FluoroSpot Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 3 ELISpot and FluoroSpot Assay Kits Market, By Technique, 2016-2023 (USD Million)
Table 4 ELISpot Assay Kits Market, By Region, 2016-2023 (USD Million)
Table 5 FluoroSpot Assay Kits Market, By Region, 2015-2023 (USD Million)
Table 6 ELISpot and FluoroSpot Assay Kits Market, By Utility, 2016-2023 (USD Million)
Table 7 Diagnostic Kits Market, By Region, 2016-2023 (USD Million)
Table 8 Research Kits Market, By Region, 2016-2023 (USD Million)
Table 9 Assay Kits Market, By Analyte, 2016-2023 (USD Million)
Table 10 T-Cell-Based Kits Market, By Region, 2016-2023 (USD Million)
Table 11 B-Cell-Based Kits Market, By Region, 2016-2023 (USD Million)
Table 12 Other Analyte Kits Market, By Region, 2016-2023 (USD Million)
Table 13 ELISpot and FluoroSpot Analyzers Market, By Region, 2016-2023 (USD Million)
Table 14 ELISpot and FluoroSpot Ancillary Products Market, By Region, 2016-2023 (USD Million)
Table 15 ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 16 ELISpot and FluoroSpot Market for Diagnostic Applications, By Type, 2016–2023 (USD Million)
Table 17 ELISpot and FluoroSpot Market for Diagnostic Applications, By Region, 2016–2023 (USD Million)
Table 18 ELISpot and FluoroSpot Market for Infectious Diseases, By Region, 2016–2023 (USD Million)
Table 19 ELISpot and FluoroSpot Market for Transplants, By Region, 2016–2023 (USD Million)
Table 20 ELISpot and FluoroSpot Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 21 ELISpot and FluoroSpot Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 22 ELISpot and FluoroSpot Market for Vaccine Development, By Region, 2016–2023 (USD Million)
Table 23 ELISpot and FluoroSpot Market for Clinical Trials, By Region, 2016–2023 (USD Million)
Table 24 ELISpot and FluoroSpot Market for Cancer Research, By Region, 2016–2023 (USD Million)
Table 25 ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 26 ELISpot and FluoroSpot Market for Hospitals & Clinical Laboratories, By Region, 2016–2023 (USD Million)
Table 27 ELISpot and FluoroSpot Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 28 ELISpot and FluoroSpot Market for Biopharmaceutical Companies, By Region, 2016–2023 (USD Million)
Table 29 ELISpot and FluoroSpot Market, By Region, 2016–2023 (USD Million)
Table 30 North America: ELISpot and FluoroSpot Market, By Country, 2016–2023 (USD Million)
Table 31 North America: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 32 North America: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 33 North America: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 34 US: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 35 US: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 36 US: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 37 Canada: ELISpot and FluoroSpot Market, By Product, 2018–2023 (USD Million)
Table 38 Canada: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 39 Canada: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 40 Europe: ELISpot and FluoroSpot Market, By Country, 2016–2023 (USD Million)
Table 41 Europe: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 42 Europe: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 43 Europe: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 44 Germany: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 45 Germany: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 46 Germany: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 47 UK: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 48 UK: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 49 UK: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 50 France: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 51 France: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 52 France: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 53 RoE: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 54 RoE: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 55 RoE: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 56 Asia Pacific: ELISpot and FluoroSpot Market, By Country, 2016–2023 (USD Million)
Table 57 Asia Pacific: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 58 Asia Pacific: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 59 Asia Pacific: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 60 China: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 61 China: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 62 China: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 63 India: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 64 India: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 65 India: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 66 Japan: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 67 Japan: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 68 Japan: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 69 RoAPAC: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 70 RoAPAC: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 71 RoAPAC: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 72 RoW: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 73 RoW: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 74 RoW: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)


List of Figures (33 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 ELISpot and FluoroSpot Market: Bottom-Up Approach
Figure 4 ELISpot and FluoroSpot Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 ELISpot and FluoroSpot Market, By Product, 2018 vs 2023 (USD Million)
Figure 7 ELISpot and FluoroSpot Market, By Application, 2018 vs 2023 (USD Million)
Figure 8 ELISpot and FluoroSpot Market, By End User, 2018 vs 2023 (USD Million)
Figure 9 ELISpot and FluoroSpot Market, By Region, 2018 vs 2023 (USD Million)
Figure 10 Rising Global Incidence of Chronic Diseases and Focus on Vaccine Development to Drive Market Growth During the Forecast Period
Figure 11 Assays Kits to Dominate the North American ELISpot and FluoroSpot Market in 2018
Figure 12 Countries in Asia to Register A Higher Growth Rate During the Forecast Period
Figure 13 ELISpot and FluoroSpot Market: Drivers, Opportunities, and Challenges
Figure 14 Assay Kits Segment to Witness the Highest Growth During the Forecast Period
Figure 15 Diagnostic Applications to Dominate the ELISpot and FluoroSpot Market During the Forecast Period
Figure 16 Total Cases of Tick-Borne Diseases in the Us, 2004–2017
Figure 17 Percentage of Registered Studies By Location (As of November 26, 2018)
Figure 18 Research Institutes Segment to Witness the Highest Growth During the Forecast Period
Figure 19 Asia Pacific to Witness the Highest Growth in the ELISpot and FluoroSpot Market During the Forecast Period
Figure 20 North America: ELISpot and FluoroSpot Market Snapshot
Figure 21 Global Vaccine Production
Figure 22 Non-Communicable Diseases in Germany
Figure 23 Non-Communicable Diseases in the UK
Figure 24 Non-Communicable Diseases in France
Figure 25 Asia Pacific: ELISpot and FluoroSpot Market Snapshot
Figure 26 Key Developments in the ELISpot and FluoroSpot Market From 2015 to 2018
Figure 27 ELISpot and FluoroSpot Market Ranking, By Key Player, 2017
Figure 28 Top Players in Research-Use Kits Market
Figure 29 Top Players in ELISpot and FluoroSpot Analyzers Market
Figure 30 Oxford Immunotec: Company Snapshot (2017)
Figure 31 BD: Company Snapshot (2017)
Figure 32 Abcam: Company Snapshot (2017)
Figure 33 Bio-Techne: Company Snapshot (2017)

The study involved four major activities to estimate the current market size for the ELISpot and FluoroSpot market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as ELISpot and FluoroSpot equipment manufacturers, vendors, and distributors and scientists, researchers, laboratory technicians, and doctors from hospitals and clinics were consulted for this report. The demand side of this market is characterized by significant use of ELISpot and FluoroSpot assay kits and instruments due to increasing chronic diseases and vaccine development across the globe. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:

ELISpot and FluoroSpot Assay Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the ELISpot and FluoroSpot market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size using the market size estimation processes the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the ELISpot and FluoroSpot industry.

Report Objectives

  • To define, describe, and forecast the ELISpot and FluoroSpot market by product, application, end user, and region
  • To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To identify the micromarkets with respect to drivers, industry-specific challenges, opportunities, and trends affecting the growth of the market
  • To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, product launches, and research and development activities in the ELISpot and FluoroSpot market.

Scope of the Report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Value (USD)

Segments covered

ELISpot and FluoroSpot product, application, end user, and region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW

Companies covered

Major 10 players covered, including
Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam (UK), Bio-Techne (US), Autoimmun Diagnostika (Germany), Biotech Investissement (France), Lophius Biosciences (Germany), and U-Cytech (The Netherlands)

This research report categorizes the ELISpot and FluoroSpot market into the following segments and subsegments:

  • ELISpot and FluoroSpot Market, by Product
    • Assay Kits
      • By Type
        • ELISpot Assay Kits
        • FluoroSpot Assay Kits
      • By Utility
        • Research
        • Diagnostic
      • By Analyte
        • T-cell-based Assays
        • B-cell-based Assays
        • Other Analyte Assays
    • Analyzers
    • Ancillary Products
  • ELISpot and FluoroSpot Market, by Application
    • Diagnostic Applications
      • Infectious Diseases
      • Transplants
    • Research Application
      • Vaccine Development
      • Clinical Trials
      • Cancer Research
  • ELISpot and FluoroSpot Market, by End User
    • Hospitals and Clinical Laboratories
    • Research Institutes
    • Biopharmaceutical Companies
  • ELISpot and FluoroSpot Market, by Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • India
      • Rest of Asia Pacific
    • Rest of the World (Latin America, the Middle East, and Africa)

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis: Further breakdown of the European, Asia Pacific, and the Rest of the into their respective countries for this market
  • Company Information: Detailed analysis and profiling of additional market players (Up to 5)
  • Volume Data: Customization Options for Volume Data (Number of Units Sold), Customization Options for Volume Data (Number of Tests)
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market
Report Code
MD 6791
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the ELISpot and FluoroSpot Assay Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved